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Congenital lung malformations: correlation between
prenatal and postnatal imaging and pathological
findings
Jean-François Lecomptea, Bastien Gondran-Tellierb, Geraldine Heryb,
Daniel Sikavib, Nathalie Colavolpec, Jean-Michel Guysb and
Pascal de Lagausieb
Aim Congenital lung malformations are a common finding
during prenatal ultrasonography (US). Investigations were
completed by means of prenatal MRI and postnatal
computed tomographic (CT) scan. The purpose of this
study was to compare these prenatal findings with
postnatal findings and pathological findings after surgical
resection.
Materials and methods Prenatal examinations and
postnatal CT scan results of congenital malformations were
compared with pathological findings.
Results From 2007 to 2013, 39 prenatally diagnosed
congenital lung malformations were resected: 18
congenital cystic adenomatoid malformation, eight
pulmonary sequestration, five bronchogenic cyst, one
bronchial atresia and six complex lesions. Correlation
between imaging and diagnosis was as follows: congenital
cystic adenomatoid malformation was seen in 17/17
patients using postnatal CT, in 10/15 patients using
prenatal MRI and in 17/18 patients using prenatal US.
Correlation between imaging and diagnosis was as follows:
bronchogenic cyst was seen in 3/5, 3/5 and 3/5 patients,
pulmonary sequestration was seen in 7/9, 5/9 and 4/9
patients, and complex lesion was seen in 4/5, 3/6, and 2/6
patients using postnatal CT, prenatal MRI, and prenatal US,
respectively. Overall, 32/37 cases were diagnosed by
means of postnatal CT, 21/36 cases were diagnosed by
means of prenatal MRI and 26/39 cases were diagnosed
by means of prenatal US.
Conclusion Discordance between imaging data and
definitive diagnosis is not rare. Our results suggest that
postnatal CT scan is the most sensible and specific
examination. Before birth, US seems better compared with
MRI for description of the lesion. MRI seems to be useful in
case of complex lesions and pulmonary
sequestration. Ann Pediatr Surg 12:82–85 c 2016 Annals
of Pediatric Surgery.
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Introduction
Congenital lung malformations are traditionally discov-
ered by means of prenatal ultrasonography (US) [1]. The
natural history of these lesions is variable based on their
histological nature, and they can grow more or less rapidly
(even leading to a hydrops), remain stable or regress
during the prenatal or postnatal period. Prenatal diag-
noses have greatly modified the evolution of these
lesions, permitting treatment before the onset of
complications.
Other prenatal and postnatal imaging techniques can be
proposed to characterize these lesions to predict their
evolution and select the most appropriate treatment for
the suspected diagnosis. Unlike radiographic computed
tomography (CT), which can only be used after birth, the
MRI can be performed during antenatal development to
characterize the lesion [2]. Discrepancies are often found
between the suspected diagnosis and the definitive
diagnosis, which appear only after an anatomopathological
examination is conducted. The objective of this study was
to compare data from prenatal imaging (US and MRI),
postnatal radiographic CTs, and anatomopathological
analyses to specify the sensitivity and specificity of these
exams in case of antenatal diagnoses of thoracic lesions.
Materials and methods
Patients receiving a prenatal diagnosis of a pulmonary
malformation by means of prenatal US were discussed in
a multidisciplinary meeting (with pediatric surgeons,
obstetrician, geneticist, prenatal radiologists and pedia-
tricians) to determine the most appropriate treatment. A
prenatal MRI was proposed between the 28th and 30th
week of amenorrhoea. In case of a strong suspicion of a
congenital cystic adenomatoid malformation (CCAM), a
second MRI was performed 4 weeks later to evaluate the
dynamics of the evolution. Patients were examined in a
consultation by a paediatric thoracic surgeon who led the
treatment of the patient. Thus, patients were subjected
to at least one US by an ultrasonographer referred by the
prenatal diagnostic centre, one prenatal MRI, and one
CT with contrast agent at 1 month of life.
The study was conducted retrospectively, and the records
of patients who had undergone operations for congenital
pulmonary malformations with a prenatal diagnosis were
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examined. The definitive diagnosis was made on the basis
of the results of anatomopathological analyses.
The following information was collected: the ultrasound
characteristics of the lesions (cystic indications, echo-
genicity and vascularization) and the suspected diagnosis
from this imaging; the MRI characteristics of the lesion
and the suspected diagnosis; and the data from the
postnatal CT. These data were compared with the
operative report and the histological analysis of the lesion.
The study was approved by Ethics committee.
Results
From February 2007 to August 2013, 39 patients were
diagnosed prenatally with congenital pulmonary malfor-
mation and underwent thoracoscopy in our unit. Twenty-
two (56%) of these patients were male and 17 (44%) were
female. US leading to a diagnosis was conducted on
average at 23.5 weeks of gestational age (18–32, median:
22.6). The last US in the reference centre was conducted
at 31.6 weeks (24–39, median: 31.7). Prenatal MRI was
performed on average at 30.6 weeks (26–36, median: 32).
Seventeen patients suspected of CCAM during the
prenatal period underwent two MRI examinations at
the end of 26.5 and at 33.2 weeks, on average. The
postnatal CTwas conducted at a median of 30 days of life
(12–358, average 74 days). All 39 patients were subjected
to at least one prenatal US by an ultrasonographer
specialized in congenital lung malformation (Fig. 1).
Thirty-six patients underwent a prenatal MRI with
HASTE, TRUFISP and T1 sequences in three planes,
without sedation or a contrasting agent injection (Fig. 2).
Three patients did not undergo an examination due to
refusal from the family. Thirty-seven patients underwent
a CT with contrast agent at 1 month of life. One patient
received a postnatal MRI due to respiratory distress
related to the malformation. The others underwent
thoracoscopy (four conversions) at a mean of 5.8 months
(2 days–22 months; median, 5 months). After a histolo-
gical analysis of the lesions, we found 18 CCAMs, nine
pulmonary sequestrations, six hybrid lesions (associated
with CCAM and pulmonary sequestration), five broncho-
genic cysts, and one bronchial atresia. The diagnostic
hypotheses from prenatal US and MRI and postnatal CT
were compared with histological data (Table 1). We then
calculated the sensitivity and specificity of the different
imaging exams for each pathology using histological
analyses as the gold standard (Table 2).
Discussion
Our study demonstrates that the different prenatal and
postnatal imaging examinations evaluated possess an
imperfect sensitivity and specificity when evaluated
against anatomopathological data. These limitations
strongly impact the treatment of these pulmonary
pathologies diagnosed during the antenatal period. The
advancement of prenatal imaging has modified the
treatment of congenital pulmonary malformations. These
lesions are only treated in case of complications or
development of symptoms related to the pathologies. As
it is possible to make a diagnosis before the onset of
clinical manifestations, monitoring and/or resection are
often proposed as preventative strategies. In these cases,
the treatment strategy depends on the suspected
diagnosis.
Prenatal US is typically the first examination conducted and
permits a screening of congenital pulmonary malformations.
Fig. 1
Prenatal ultrasonography: congenital cystic adenomatoid malformation.
Fig. 2
Prenatal MRI: congenital cystic adenomatoid malformation in the right
upper lobe.
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However, the sensitivity of this technique is rather poor
for bronchogenic cysts (0.6), pulmonary sequestrations
(0.6) and especially complex lesions (0.16). Prenatal US
allows for an effective detection of malformations without
characterizing them [3]. Our results indicate a very high
specificity of this technique for bronchogenic cysts (1),
pulmonary sequestrations (1), and complex lesions (0.9).
Therefore, prenatal US may be sufficient upon initial
diagnosis of these malformations.
Prenatal MRI possesses roughly the same sensitivity and
specificity as US. The sensitivity of prenatal MRI is quite
poor for bronchogenic cysts (0.6) and pulmonary seques-
trations (0.55). However, MRI permits a better screening
for complex lesions, with improved sensitivity as com-
pared with prenatal US (0.5 vs. 0.16). MRI also offers an
improved diagnostic specificity for CCAM (0.66 vs. 0.5),
but not for other lesions. MRI may be useful principally
for screening of these complex lesions that represent 20
to 40% of congenital pulmonary malformations [4,5].
Postnatal CT had the highest reported sensitivity for
CCAM. However, its specificity does not exceed that of
US or prenatal MRI for bronchogenic cysts, pulmonary
sequestrations, and complex lesions. In contrast, it offers
a greater diagnostic sensitivity for these lesions. In all
cases, it appears essential to evaluate the lesion during
the postnatal period and determine the most appropriate
treatment [6,7].
Given our findings, upon diagnosis of a bronchogenic cyst
or pulmonary sequestration during an US examination,
prenatal MRI and postnatal CT may not be useful to
establish the diagnosis. However, prenatal MRI and
postnatal CT may be useful for evaluating the impact
of the lesion on the rest of the parenchyma. Similarly,
when this diagnosis is not made by means of US, but only
by means of prenatal MRI, CT is not always necessary for
a more accurate diagnosis. A postnatal MRI may be
performed, but its usefulness must be evaluated in future
investigations. However, in case of a suspicion of CCAM,
the most frequently suspected lesion during the prenatal
period, the three exams together allow for a more precise
diagnostic approach [3].
For pulmonary sequestrations, US and prenatal MRI
possess an equally weak sensitivity (0.44 and 0.55,
respectively); however, their specificity is excellent (1).
In contrast, CT only possesses a sensitivity of 0.77. As a
result, the discovery of an aberrant artery is frequently
realized only during surgery. Therefore, this malformation
must be systematically sought at the beginning of the
intervention, regardless of the suspected preoperative
diagnosis. This exploration is particularly important in
inferior lobar malformations in which frequency of this
malformation is the greatest.
The three imaging techniques do not differ in their
sensitivity in diagnosing bronchogenic cysts, which is
uniformly poor (0.6). In contrast, their specificity is high
(0.96–1). When this diagnosis is suspected, an initial
surgical exploration must be conducted to better
characterize the bronchogenic cyst, and determine
whether a cystectomy is possible. The diagnosis is
refined perioperatively (all of our patients underwent a
cystectomy in these cases, avoiding a parenchymal
resection). All these treatments are based on the
suspected prenatal diagnoses using different imaging
strategies. Surgical indications of resection are stricter in
case of cystic lesions due to the risk for infection and
degeneration [3,8]. The ability to make a preoperative
diagnosis is important for the preoperative and perio-
perative treatment strategy and for informing parents.
This study identifies important deficiencies in each
imaging technique examined. We found that the sensi-
tivity of prenatal US and MRI is relatively poor. Postnatal
CT with intravenous contrast agents remains the
examination that best optimizes sensitivity and specifi-
city for all investigated congenital pulmonary malforma-
tions. Nevertheless, a single imaging examination is not
always sufficient to make a precise diagnosis. US allows
for a screening of congenital pulmonary malformations.
MRI offers an improved detection of complex lesions
(with CCAM + / – sequestration + / – bronchogenic
cystic components), but these examinations alone are not
sufficient to make an accurate diagnosis.
Regardless of the suspected prenatal diagnosis and the
monitoring or proposed resection by the medical team, a
complementary postnatal CT with intravenous contrast
agent must be conducted. This approach allows for the
most precise diagnosis and a re-evaluation of the
proposed therapeutic strategy. This strategy is essential
for complex lesions undiagnosed by means of prenatal
imaging (due to the poor sensitivity of MRI and US for
these lesions). In such cases, the CCAM or bronchogenic
Table 1 Correlations between histological analyses and prenatal
and postnatal imaging data
Correlation with pathological finding
Diagnosis an pathological
exam and number Postnatal CT Prenatal MRI Prenatal US
CCAM 18 17/17 10/15 17/18
Bronchogenic cyst 5 3/5 3/5 3/5
Pulmonary sequestration 9 7/9 5/9 4/9
Hybrid lesion 6 4/5 3/6 2/6
Bronchial atresia 1 1/1 0/1 0/1
Total 39 32/37 21/36 26/39
CCAM, congenital cystic adenomatoid malformation; CT, computed tomography;
US, ultrasonography.
Table 2 Sensitivity and specificity (%) of the imaging techniques
for several pathologies
Postnatal CT Prenatal MRI Prenatal US
CCAM
Sensitivity 1 0.66 0.89
Specificity 0.85 0.66 0.5
Bronchogenic cyst
Sensitivity 0.6 0.6 0.6
Specificity 1 0.96 1
Pulmonary sequestration
Sensitivity 0.77 0.55 0.44
Specificity 0.96 1 1
Complex lesion
Sensitivity 0.8 0.5 0.16
Specificity 0.96 0.83 0.9
CCAM, congenital cystic adenomatoid malformation; CT, computed tomography;
US, ultrasonography.
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cystic components must be treated thoroughly compared
with the sequestration components, because of the
greater frequency of complications in the former. Never-
theless, despite the reliability of CT exams, given our
results, five patients out of 37 (14%) had a definitive
diagnosis that differed from that made with postnatal CT
imaging.
Therefore, the treatment of these patients must be
discussed on a case-by-case basis, using the results of
different imaging examinations to make the most accurate
lesional diagnosis. However, the diagnosis cannot be
certain before the excision of the lesion. This limitation
must be taken into account during the prenatal consulta-
tion so as to have the most prepared discussion about the
predicted evolution of the lesion and the possible need for
preventative excision. Using these various imaging tech-
niques together and by recognizing the relative strengths
and limitations of each in diagnosing a range of possible
pathologies, physicians will be better equipped to make
the most accurate diagnosis and propose the most
appropriate treatment strategy for patients.
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